MELA Sciences, Inc. (NASDAQ:MELA), developer of MelaFind®, an FDA-approved optical diagnostic device that assists dermatologists in the diagnosis of melanoma, will host its third company-sponsored Clinical Advisory meeting for select dermatologists and key opinion leaders in melanoma and provide recent clinical findings at the Winter Clinical Dermatology Conference being held January 17-22 at the Fairmont Orchid Hotel, Kona Coast, Hawaii.
Help employers find you! Check out all the jobs and post your resume.
